HomeGENE • NASDAQ
add
Genetic Technologies Limited
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.40M | -10.62% |
Operating expense | 4.11M | 0.23% |
Net income | -2.80M | 11.01% |
Net profit margin | -116.63 | 0.44% |
Earnings per share | — | — |
EBITDA | -2.59M | -4.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.04M | -86.79% |
Total assets | 6.19M | -58.36% |
Total liabilities | 4.36M | 17.93% |
Total equity | 1.83M | — |
Shares outstanding | 145.42M | — |
Price to book | 76.50 | — |
Return on assets | -109.72% | — |
Return on capital | -250.89% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.80M | 11.01% |
Cash from operations | -2.83M | -57.81% |
Cash from investing | 12.46K | -74.48% |
Cash from financing | 1.50M | -50.75% |
Net change in cash | -1.35M | -196.53% |
Free cash flow | -1.52M | -13.11% |
About
Founded
1987
Website
Employees
55
